Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VANI

Vivani Medical Inc

Oct 04 • 04:00PM ET

1.18

Dollar change +0.06
Percentage change 5.36	%

Healthcare • Biotechnology • USA • NASD

Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.46	Insider Own	45.36%	Shs Outstand	51.03M	Perf Week	3.96%
Market Cap	65.21M	Forward P/E	-	EPS next Y	-0.50	Insider Trans	0.05%	Shs Float	30.19M	Perf Month	-3.28%
Income	-24.20M	PEG	-	EPS next Q	-0.11	Inst Own	10.31%	Short Float	2.87%	Perf Quarter	-6.35%
Sales	0.00M	P/S	-	EPS this Y	12.00%	Inst Trans	-6.06%	Short Ratio	9.56	Perf Half Y	-41.00%
Book/sh	0.43	P/B	2.73	EPS next Y	-13.64%	ROA	-44.89%	Short Interest	0.87M	Perf Year	14.56%
Cash/sh	0.45	P/C	2.62	EPS next 5Y	-	ROE	-86.10%	52W Range	0.84 - 7.80	Perf YTD	15.69%
Dividend Est.	-	P/FCF	-	EPS past 5Y	47.53%	ROI	-57.03%	52W High	-84.87%	Beta	3.23
Dividend TTM	-	Quick Ratio	4.55	Sales past 5Y	-30.20%	Gross Margin	-	52W Low	40.48%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	4.55	EPS Y/Y TTM	-29.35%	Oper. Margin	0.00%	RSI (14)	46.99	Volatility	4.48% 4.42%
Employees	44	Debt/Eq	0.84	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	8.00
Option/Short	Yes / Yes	LT Debt/Eq	0.78	EPS Q/Q	24.28%	Payout	-	Rel Volume	1.00	Prev Close	1.12
Sales Surprise	-	EPS Surprise	16.67%	Sales Q/Q	-	Earnings	Aug 13 AMC	Avg Volume	90.64K	Price	1.18
SMA20	-1.73%	SMA50	-4.40%	SMA200	-18.67%	Trades		Volume	90,309	Change	5.36%

Sep-27-24 06:12AM	Vivani Medical obtains Australian approval to begin GLP-1 implant trial (Medical Device Network)
Sep-26-24 12:00PM	Vivani Medical to Test Implant in Obese and Overweight Patients (Exec Edge)
08:30AM	Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia (Business Wire)
08:00AM	EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia (Benzinga)
Sep-25-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 2 on September 26 (GlobeNewswire)
07:00AM	Loading…
Sep-24-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now (GlobeNewswire)
Sep-23-24 08:57AM	Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024 (Business Wire)
Sep-04-24 08:00AM	Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant (Business Wire)
07:33AM	EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity (Benzinga)
Aug-28-24 07:10PM	Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-13-24 04:25PM	Vivani Medical: Q2 Earnings Snapshot (Associated Press Finance) +8.62%
04:05PM	Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-12-24 06:52AM	Vivani to start in-human trial for GLP-1 implant for treating obesity (Medical Device Network)
Jul-11-24 08:00AM	Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115 (Business Wire) +5.60%
07:29AM	EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year (Benzinga)
12:58PM	Loading…
Jun-13-24 12:58PM	Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant (Exec Edge)
08:25AM	EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED) (Benzinga)
08:00AM	Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant (Business Wire)
May-28-24 09:30AM	EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use (Benzinga)
08:00AM	Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant (Business Wire)
May-13-24 08:52PM	VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024 (InvestorPlace)
04:55PM	Vivani Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:45PM	Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results (Business Wire)
May-09-24 08:00AM	Vivani Medical to Present at TIDES Conference 2024 (Business Wire)
Mar-26-24 09:02PM	Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com)
01:52PM	VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023 (InvestorPlace)
08:38AM	Vivani Medical: Q4 Earnings Snapshot (Associated Press Finance)
08:30AM	Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-06-24 08:00AM	Vivani Medical Appoints Daniel Bradbury to its Board of Directors (Business Wire)
Mar-01-24 07:49AM	Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants (Business Wire) -26.78%
01:59PM	Loading…
Feb-28-24 01:59PM	Why Is Vivani Medical (VANI) Stock Up 300% Today? (InvestorPlace) +270.30%
08:30AM	Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic/Wegovy and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio (Business Wire)
Nov-14-23 06:10AM	Vivani Medical: Q3 Earnings Snapshot (Associated Press Finance) -6.27%
06:00AM	Vivani Medical Provides Business Update and Reports Third Quarter Financial Results (Business Wire)
Oct-16-23 06:00AM	Vivani Medical to Present at BIO Investor Forum (Business Wire)
Sep-13-23 09:25PM	Director Gregg Williams Acquires 13,997 Shares of Vivani Medical Inc (VANI) (GuruFocus.com)
Sep-07-23 06:00AM	Vivani Medical to Present at the Boulder Peptide Symposium (Business Wire)
Sep-05-23 06:00AM	Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10 (Business Wire)
Aug-14-23 05:56PM	Vivani Medical: Q2 Earnings Snapshot (Associated Press Finance) -10.66%
05:45PM	Vivani Medical Reports Second Quarter Financial Results and Provides Business Update (Business Wire)
Jul-11-23 06:00AM	Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System (Business Wire)
Jun-14-23 06:00AM	Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest (Business Wire)
Jun-13-23 06:05AM	Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth? (Simply Wall St.) +16.30%
May-15-23 06:21AM	Vivani Medical: Q1 Earnings Snapshot (AP Finance) -5.80%
06:15AM	Vivani Medical Reports First Quarter Financial Results and Provides Business Update (Business Wire)
May-03-23 06:57AM	Insiders of Vivani Medical, Inc. (NASDAQ:VANI) received good value on their investment after their US$2.2m purchase jumped US$593k in value (Simply Wall St.) +5.84%
06:26AM	Insider Buying: The Vivani Medical, Inc. (NASDAQ:VANI) Director Just Bought 15% More Shares (Simply Wall St.)
Apr-04-23 06:00AM	Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigents Ongoing Orion Clinical Study (Business Wire)
Mar-31-23 02:50PM	Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-21-23 06:00AM	Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division (Business Wire)
Dec-01-22 09:42AM	We're Hopeful That Vivani Medical (NASDAQ:VANI) Will Use Its Cash Wisely (Simply Wall St.)
Nov-14-22 04:46PM	Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates (Business Wire) -5.33%
Oct-17-22 06:00AM	Vivani Medical to Present at the ThinkEquity Investor Conference (Business Wire)

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dwyer Donald	Chief Business Officer	Oct 01 '24	Buy	1.14	1,000	1,140	48,500	Oct 03 06:10 PM
Dwyer Donald	Chief Business Officer	Oct 02 '24	Buy	1.13	1,000	1,130	49,500	Oct 03 06:10 PM
Dwyer Donald	Chief Business Officer	Oct 03 '24	Buy	1.13	500	565	50,000	Oct 03 06:10 PM
Dwyer Donald	Chief Business Officer	Jul 30 '24	Buy	1.24	5,000	6,200	43,500	Aug 01 08:40 PM
Dwyer Donald	Chief Business Officer	Jul 31 '24	Buy	1.23	4,000	4,920	47,500	Aug 01 08:40 PM
Dwyer Donald	Chief Business Officer	Nov 22 '23	Buy	0.96	2,000	1,920	38,500	Aug 01 08:27 PM
Williams Gregg	Director	Feb 15 '24	Buy	1.01	1,078	1,089	727,608	Feb 20 06:32 PM
Williams Gregg	Director	Feb 08 '24	Buy	1.01	1,119	1,130	725,459	Feb 09 08:02 PM
Williams Gregg	Director	Feb 09 '24	Buy	1.01	1,071	1,082	726,530	Feb 09 08:02 PM
Williams Gregg	Director	Feb 05 '24	Buy	1.01	1,939	1,958	724,284	Feb 06 06:35 PM
Williams Gregg	Director	Feb 06 '24	Buy	1.01	56	57	724,340	Feb 06 06:35 PM
Williams Gregg	Director	Jan 31 '24	Buy	1.01	100	101	722,345	Feb 02 08:04 PM
Williams Gregg	Director	Jan 23 '24	Buy	1.01	834	842	722,245	Jan 25 06:31 PM
Williams Gregg	Director	Jan 22 '24	Buy	1.01	7,620	7,696	721,411	Jan 22 06:54 PM
Williams Gregg	Director	Jan 18 '24	Buy	1.01	999	1,009	713,714	Jan 19 07:27 PM
Williams Gregg	Director	Jan 19 '24	Buy	1.01	77	78	713,791	Jan 19 07:27 PM
Williams Gregg	Director	Jan 16 '24	Buy	1.01	13,067	13,198	712,715	Jan 16 07:24 PM
Williams Gregg	Director	Jan 08 '24	Buy	1.08	6,731	7,269	699,648	Jan 09 08:10 PM
Williams Gregg	Director	Jan 04 '24	Buy	1.07	4,200	4,494	690,917	Jan 05 06:57 PM
Williams Gregg	Director	Jan 05 '24	Buy	1.08	2,000	2,160	692,917	Jan 05 06:57 PM
Williams Gregg	Director	Jan 03 '24	Buy	1.01	3,563	3,599	686,717	Jan 03 08:40 PM
Williams Gregg	Director	Jan 02 '24	Buy	1.01	3,548	3,583	683,154	Jan 03 08:40 PM
Williams Gregg	Director	Dec 22 '23	Buy	1.00	100	100	679,606	Dec 27 06:15 PM
Williams Gregg	Director	Dec 21 '23	Buy	0.88	149,940	131,947	679,506	Dec 21 08:08 PM
Williams Gregg	Director	Dec 20 '23	Buy	0.88	3,734	3,286	529,566	Dec 21 08:08 PM
Williams Gregg	Director	Dec 19 '23	Buy	0.86	198	170	525,832	Dec 21 08:08 PM
Williams Gregg	Director	Dec 18 '23	Buy	0.90	2,000	1,800	525,634	Dec 18 08:29 PM
Williams Gregg	Director	Dec 15 '23	Buy	0.89	2,000	1,780	523,634	Dec 18 08:29 PM
Williams Gregg	Director	Dec 14 '23	Buy	0.88	301	265	521,634	Dec 18 08:29 PM
Makes Brigid	CFO	Dec 15 '23	Buy	0.89	4,000	3,560	14,000	Dec 18 08:27 PM
Makes Brigid	CFO	Dec 18 '23	Buy	0.87	1,000	870	15,000	Dec 18 08:27 PM
Williams Gregg	Director	Dec 11 '23	Buy	0.89	28,948	25,764	520,475	Dec 13 07:46 PM
Williams Gregg	Director	Dec 13 '23	Buy	0.87	858	746	521,333	Dec 13 07:46 PM
Williams Gregg	Director	Dec 06 '23	Buy	0.96	993	953	491,527	Dec 08 07:15 PM
Williams Gregg	Director	Nov 24 '23	Buy	0.95	2,694	2,559	490,534	Nov 27 06:23 PM
Williams Gregg	Director	Nov 22 '23	Buy	0.95	769	731	487,840	Nov 27 06:23 PM
Dwyer Donald	Chief Business Officer	Nov 20 '23	Buy	0.96	2,500	2,400	33,500	Nov 22 05:04 PM
Dwyer Donald	Chief Business Officer	Nov 21 '23	Buy	0.96	2,000	1,920	35,500	Nov 22 05:04 PM
Dwyer Donald	Chief Business Officer	Nov 22 '23	Buy	0.96	1,000	960	36,500	Nov 22 05:04 PM
Williams Gregg	Director	Nov 16 '23	Buy	0.95	2,015	1,914	485,820	Nov 20 08:36 PM
Williams Gregg	Director	Nov 17 '23	Buy	0.95	1,251	1,188	487,071	Nov 20 08:36 PM
Williams Gregg	Director	Oct 23 '23	Buy	1.00	100,565	100,565	482,583	Oct 24 06:44 PM
Williams Gregg	Director	Oct 20 '23	Buy	1.00	1,581	1,581	382,018	Oct 24 06:44 PM
Williams Gregg	Director	Oct 24 '23	Buy	1.00	1,222	1,222	483,805	Oct 24 06:44 PM
Williams Gregg	Director	Oct 13 '23	Buy	1.01	9,414	9,508	378,837	Oct 16 06:12 PM
Williams Gregg	Director	Oct 16 '23	Buy	1.00	1,600	1,600	380,437	Oct 16 06:12 PM
Williams Gregg	Director	Oct 12 '23	Buy	1.00	1,405	1,405	369,423	Oct 16 06:12 PM
Williams Gregg	Director	Oct 09 '23	Buy	1.00	664	664	368,018	Oct 11 09:08 PM
Williams Gregg	Director	Oct 06 '23	Buy	1.02	87,887	89,645	367,354	Oct 10 08:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VANI

Vivani Medical Inc

Upgrade your FINVIZ experience